Associate Professor, Medicine, Tufts Medical Center
Infectious Disease
Dr. Debra D. Poutsiaka, MD
|
|
Give Review
Debra Poutsiaka is an expert in the field of Infectious Disease. She attended Boston University School of Medicine. Boston University School of Medicine is ranked 30 in research and 52 in primary care medicine She received awards:"Regional Top Doctor". Dr. Debra D. Poutsiaka has written publications. She has 26 publications published with PubMed. The lastest paper is: 'Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans.' Doctor Debra D. Poutsiaka, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients.
- No Evidence of Harms of Probiotic Lactobacillus rhamnosus GG ATCC 53103 in Healthy Elderly-A Phase I Open Label Study to Assess Safety, Tolerability and Cytokine Respo...
- Late and atypical cytomegalovirus disease in solid-organ transplant recipients.
- Antimicrobial resistance in the chronically critically ill patient.
- Daptomycin for line-related Leuconostoc bacteraemia.
- Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans.
- Comparison of first use and reuse of cuprophan membranes on interleukin-1 receptor antagonist and interleukin-1 beta production by blood mononuclear cells.
- Measuring circulating cytokines.
- Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans.
- Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitro.
- Cross-linking of the beta-glucan receptor on human monocytes results in interleukin-1 receptor antagonist but not interleukin-1 production.
- Turnover and fate of I-Ak antigen on the murine macrophage cell surface.
- Inhibition of recombinant interferon-gamma-induced Ia antigen expression by shed B16 F10 melanoma cell membrane vesicles.
- Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia antigen by macrophages.
- Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated.
- Production of interleukin-1-receptor antagonist during experimental endotoxaemia.
- Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes.
- Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease.
- Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells.
- In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD.
- Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood.
- Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated.
- Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis.
- Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.
- Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.
Schools
Boston University School Of Medicine
Beth Israel Deaconess Hospital
New Eng Med Center
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Tufts Medical Center -
Beth Israel Deaconess Medical Center -
Boston University School of Medicine
Hospital
-
Tufts Medical Center
Drug Facts
| NPI NUMBER | 1518982701 | |
| NPPES Provider LastName | POUTSIAKA | |
| NPPES Provider FirstName | DEBRA | |
| NPPES Provider ZIPCode | 021111526 | |
| NPPES Provider State | MA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 21.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1518982701 |
| Last Name Of The Provider | POUTSIAKA |
| First Name Of The Provider | DEBRA |
| View All |
Similar Doctors
|
|
Dr. Sonya S. Shin, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Justin R. Bailey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Hale, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa A. Cosimi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David S. Yassa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory K. Robbins, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Alexander D. Macalalad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sherwood L. Gorbach, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Lee M. Wetzler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles R. Horsburgh, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Carol A. Sulis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Emilia L. Falcone |